PubRank

A Tibben

Author PubWeight™ 51.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet 1997 2.27
2 [Familial forms of fronto-temporal dementia]. Ned Tijdschr Geneeskd 1995 2.04
3 High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 1999 1.87
4 Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. Am J Hum Genet 1994 1.34
5 Recommendations for the predictive genetic test in Huntington's disease. Clin Genet 2012 1.27
6 Frontotemporal dementia: behavioral symptoms and caregiver distress. Dement Geriatr Cogn Disord 2004 1.19
7 New problems in testing for Huntington's disease: the issue of intermediate and reduced penetrance alleles. J Med Genet 2001 1.19
8 Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet 2007 1.16
9 Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup. J Med Genet 1997 1.15
10 Caregiver burden, health-related quality of life and coping in dementia caregivers: a comparison of frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord 2006 1.10
11 Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 2001 1.09
12 Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: a genetic and clinicopathological study of three Dutch families. Ann Neurol 1997 1.09
13 Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup. J Med Genet 1998 1.08
14 BRCA1 in the family: a case description of the psychological implications. Am J Med Genet 1997 1.03
15 Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group. J Med Genet 1999 1.02
16 Understanding the low uptake of presymptomatic DNA testing for Huntington's disease. Lancet 1992 1.01
17 Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease. Arch Neurol 1997 1.00
18 Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Ann Oncol 2006 0.96
19 Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup. Am J Med Genet 1998 0.96
20 Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. Eur J Hum Genet 2001 0.95
21 Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Brain 2000 0.93
22 Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results. Clin Genet 2010 0.92
23 Turkish female immigrants' intentions to participate in preconception carrier screening for hemoglobinopathies in the Netherlands: an empirical study. Public Health Genomics 2010 0.92
24 Impact of screening for breast cancer in high-risk women on health-related quality of life. Br J Cancer 2004 0.92
25 Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation. J Med Genet 2002 0.91
26 The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. Eur J Cancer 2006 0.91
27 Testing for Huntington's disease with support for all parties. Lancet 1990 0.89
28 International variation in physicians' attitudes towards prophylactic mastectomy - comparison between France, Germany, the Netherlands and the United Kingdom. Eur J Cancer 2013 0.89
29 Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: an explorative study. Rotterdam/Leiden Genetics Workgroup. Psychosom Med 1998 0.87
30 Psychosocial aspects of preconception consultation in primary care: lessons from our experience in clinical genetics. J Community Genet 2012 0.87
31 Subtle involuntary movements are not reliable indicators of incipient Huntington's disease. Mov Disord 1998 0.84
32 Adverse childhood experiences of persons at risk for Huntington's disease or BRCA1/2 hereditary breast/ovarian cancer. Clin Genet 2011 0.84
33 Screening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group. J Med Genet 1999 0.84
34 Psychological studies in Huntington's disease: making up the balance. J Med Genet 2001 0.84
35 Passive coping and psychological distress in women adhering to regular breast cancer surveillance. Psychooncology 2007 0.84
36 Psychological consequences of presymptomatic testing for Huntington's disease. Lancet 1997 0.82
37 Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy? Ann Oncol 2007 0.82
38 Cancer genetics service provision: a comparison of seven European centres. Community Genet 2003 0.81
39 Attitudes of Dutch general practitioners towards presymptomatic DNA-testing for Huntington disease. Clin Genet 1993 0.81
40 Behavioural complaints in participants who underwent predictive testing for Huntington's disease. J Med Genet 2002 0.79
41 Familial breast cancer: is it time to move from a reactive to a proactive role? Fam Cancer 2011 0.79
42 Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer. Community Genet 2003 0.79
43 Prenatal testing for Huntington's disease in the Netherlands from 1998 to 2008. Clin Genet 2013 0.78
44 Hereditary melanoma and predictive genetic testing: why not? Psychooncology 2005 0.78
45 Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer. Hum Reprod 2014 0.78
46 Preliminary experience with predictive testing for insulin-dependent diabetes mellitus. Lancet 1995 0.77
47 DNA testing for fragile X syndrome: implications for parents and family. J Med Genet 1997 0.76
48 A decade of genetic counseling in frontotemporal dementia affected families: few counseling requests and much familial opposition to testing. J Genet Couns 2009 0.76
49 Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflections. Hum Reprod Update 2013 0.76
50 Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review. J Med Genet 2004 0.75
51 Intelligence indices in people with a high/low risk for developing Huntington's disease. J Med Genet 1997 0.75
52 Evaluation of exclusion prenatal and exclusion preimplantation genetic diagnosis for Huntington's disease in the Netherlands. Clin Genet 2012 0.75
53 Nonlinear effects in behavioral changes in Huntington disease. Cogn Behav Neurol 2003 0.75
54 [Hereditary breast and/or ovarian cancer: consequences for family relations]. Oncologica 1997 0.75
55 Coping with genetic burden. Acta Neuropsychiatr 1999 0.75
56 Dilemmas in counselling females with the fragile X syndrome. J Med Genet 1999 0.75
57 Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level? Clin Genet 2010 0.75
58 [A large-scale diagnostic program for the fragile X-syndrome among the mentally retarded. II. Implications for parents and family]. Ned Tijdschr Geneeskd 1998 0.75
59 [Procedure and initial results of presymptomatic DNA studies in Huntington's chorea]. Ned Tijdschr Geneeskd 1990 0.75
60 [New insights in frontotemporal dementia]. Ned Tijdschr Geneeskd 2000 0.75
61 Prenatal consultation after a fetal anomaly scan: videotaped exploration of physician's attitude and patient's satisfaction. Prenat Diagn 1999 0.75
62 Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer. Lancet 1994 0.75
63 Calculating risk changes after negative mutation test outcomes for autosomal dominant hereditary late-onset disorders. Heredity (Edinb) 2006 0.75